QuidelOrtho (QDEL) Liabilities and Shareholders Equity (2022 - 2026)
QuidelOrtho (QDEL) posted Liabilities and Shareholders Equity of $5.6 billion for Q1 2026, down 2.44% sequentially from $5.8 billion in Q4 2025, and down 12.89% YoY from $6.5 billion in Q1 2025.
QuidelOrtho (QDEL) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends
QuidelOrtho has reported Liabilities and Shareholders Equity for 5 years, with the latest figure at $5.6 billion in Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 12.89% year-over-year to $5.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.5 billion (down 11.08% YoY) and the FY2025 annual result came in at $5.8 billion, down 10.19% from the prior year.
- Liabilities and Shareholders Equity retreated to $5.6 billion in Q1 2026 per QDEL's latest filing, from $5.8 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $8.9 billion in Q1 2023 and troughed at $2.4 billion in Q1 2022.
- A 5-year average of $7.0 billion and a median of $6.7 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity jumped 264.38% in 2023, then fell 24.99% in 2024.
- Over 5 years, Liabilities and Shareholders Equity stood at $8.7 billion in 2022, then decreased by 1.07% to $8.6 billion in 2023, then fell by 24.99% to $6.4 billion in 2024, then dropped by 10.19% to $5.8 billion in 2025, then retreated by 2.44% to $5.6 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $5.6 billion, $5.8 billion, and $5.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 10.74 Bn |
| 10 | QuidelOrtho | 1.01 Bn | 885.73 Mn | - | 5.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 5.72 Bn |
| Mar 29, 2026 | 5.63 Bn |
| Dec 28, 2025 | 5.77 Bn |
| Sep 28, 2025 | 5.68 Bn |
| Jun 29, 2025 | 6.38 Bn |
| Mar 30, 2025 | 6.46 Bn |
| Dec 29, 2024 | 6.42 Bn |
| Sep 29, 2024 | 6.80 Bn |
| Jun 30, 2024 | 6.69 Bn |
| Mar 31, 2024 | 6.70 Bn |
| Dec 31, 2023 | 8.56 Bn |
| Oct 1, 2023 | 8.54 Bn |
| Jul 2, 2023 | 8.55 Bn |
| Apr 2, 2023 | 8.79 Bn |
| Jan 1, 2023 | 8.86 Bn |
| Oct 2, 2022 | 8.66 Bn |
| Jul 3, 2022 | 8.82 Bn |
| Jan 2, 2022 | 2.43 Bn |